Skip to search formSkip to main contentSkip to account menu

HAO472

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

AlanineDiterpenes, Kaurane
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Recent Progress of Oridonin and Its Derivatives for the Treatment of Acute Myelogenous Leukemia.
HAO472, the L-alanine-(14-oridonin) ester trifluoroacetate, was conducted first stage human clinical trial (CTR20150246) by a… 
2019
2019
Effective enmein-type mimics of clinical candidate HAO472: Design, synthesis and biological evaluation.
2016
2016
Oridonin derivative ameliorates experimental colitis by inhibiting activated T‐cells and translocation of nuclear factor‐kappa B
To confirm the potential therapeutic efficacy of HAO472 against inflammatory bowel disease (IBD), we investigated the modulatory… 
Review
2016
Review
2016
Discovery and development of natural product oridonin-inspired anticancer agents.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)